Shimizu et al. identified a mechanism in which MCL-1 stability is increased in breast and prostate cancer cell lines through acetylation by p300, which enhances the de-ubiquitinating function of USP9X, facilitating apoptosis evasion [25]. Here, USP9X is linked to prostate cancer.